125 related articles for article (PubMed ID: 21621603)
1. Safety of infliximab use during pregnancy.
Djokanovic N; Klieger-Grossmann C; Pupco A; Koren G
Reprod Toxicol; 2011 Jul; 32(1):93-7. PubMed ID: 21621603
[TBL] [Abstract][Full Text] [Related]
2. Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn.
Vasiliauskas EA; Church JA; Silverman N; Barry M; Targan SR; Dubinsky MC
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1255-8. PubMed ID: 17045211
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease.
Cheent K; Nolan J; Shariq S; Kiho L; Pal A; Arnold J
J Crohns Colitis; 2010 Nov; 4(5):603-5. PubMed ID: 21122568
[TBL] [Abstract][Full Text] [Related]
4. Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery.
Kane S; Ford J; Cohen R; Wagner C
J Clin Gastroenterol; 2009 Aug; 43(7):613-6. PubMed ID: 19142167
[TBL] [Abstract][Full Text] [Related]
5. High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy.
Zelinkova Z; de Haar C; de Ridder L; Pierik MJ; Kuipers EJ; Peppelenbosch MP; van der Woude CJ
Aliment Pharmacol Ther; 2011 May; 33(9):1053-8. PubMed ID: 21366638
[TBL] [Abstract][Full Text] [Related]
6. Treatment of psoriasis with anti-TNF drugs during pregnancy: case report and review of the literature.
Puig L; Barco D; Alomar A
Dermatology; 2010; 220(1):71-6. PubMed ID: 19940453
[TBL] [Abstract][Full Text] [Related]
7. Emerging data on the use of anti-tumor necrosis factor-alpha medications in pregnancy.
Chambers CD; Johnson DL
Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):607-11. PubMed ID: 22786755
[TBL] [Abstract][Full Text] [Related]
8. A Narrative Review on Anti-Tumor Necrosis Factor α Therapies in Inflammatory Bowel Disease During Pregnancy: Immunoglobulin Placental Translocation and its Impact.
Roseira J; Ramos J
Acta Med Port; 2019 Apr; 32(4):305-312. PubMed ID: 31067425
[TBL] [Abstract][Full Text] [Related]
9. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis.
Katz JA; Antoni C; Keenan GF; Smith DE; Jacobs SJ; Lichtenstein GR
Am J Gastroenterol; 2004 Dec; 99(12):2385-92. PubMed ID: 15571587
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection.
Julsgaard M; Christensen LA; Gibson PR; Gearry RB; Fallingborg J; Hvas CL; Bibby BM; Uldbjerg N; Connell WR; Rosella O; Grosen A; Brown SJ; Kjeldsen J; Wildt S; Svenningsen L; Sparrow MP; Walsh A; Connor SJ; Radford-Smith G; Lawrance IC; Andrews JM; Ellard K; Bell SJ
Gastroenterology; 2016 Jul; 151(1):110-9. PubMed ID: 27063728
[TBL] [Abstract][Full Text] [Related]
11. [Infectious risk].
Calabuig E; Salavert M
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():14-22. PubMed ID: 19080987
[TBL] [Abstract][Full Text] [Related]
12. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.
Bendtzen K; Geborek P; Svenson M; Larsson L; Kapetanovic MC; Saxne T
Arthritis Rheum; 2006 Dec; 54(12):3782-9. PubMed ID: 17133559
[TBL] [Abstract][Full Text] [Related]
13. How to improve the safety of biologic therapy in Crohn's disease.
Ferkolj I
J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():67-70. PubMed ID: 20388947
[TBL] [Abstract][Full Text] [Related]
14. Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system.
Wieringa JW; Driessen GJ; Van Der Woude CJ
Expert Rev Gastroenterol Hepatol; 2018 Aug; 12(8):811-818. PubMed ID: 29972674
[TBL] [Abstract][Full Text] [Related]
15. The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial.
Korhonen T; Karppinen J; Paimela L; Malmivaara A; Lindgren KA; Bowman C; Hammond A; Kirkham B; Järvinen S; Niinimäki J; Veeger N; Haapea M; Torkki M; Tervonen O; Seitsalo S; Hurri H
Spine (Phila Pa 1976); 2006 Nov; 31(24):2759-66. PubMed ID: 17108825
[TBL] [Abstract][Full Text] [Related]
16. How safe is infliximab therapy during pregnancy and lactation in inflammatory bowel disease?
Chaparro M; Gisbert JP
Expert Opin Drug Saf; 2014 Dec; 13(12):1749-62. PubMed ID: 25244582
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid arthritis and pregnancy: impediments to optimal management of both biologic use before, during and after pregnancy.
Williams M; Chakravarty EF
Curr Opin Rheumatol; 2014 May; 26(3):341-6. PubMed ID: 24663107
[TBL] [Abstract][Full Text] [Related]
18. Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004.
O'Leary DR; Kuhn S; Kniss KL; Hinckley AF; Rasmussen SA; Pape WJ; Kightlinger LK; Beecham BD; Miller TK; Neitzel DF; Michaels SR; Campbell GL; Lanciotti RS; Hayes EB
Pediatrics; 2006 Mar; 117(3):e537-45. PubMed ID: 16510632
[TBL] [Abstract][Full Text] [Related]
19. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
Gómez-Reino JJ; Carmona L; Valverde VR; Mola EM; Montero MD;
Arthritis Rheum; 2003 Aug; 48(8):2122-7. PubMed ID: 12905464
[TBL] [Abstract][Full Text] [Related]
20. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
